Chinese Journal of Tissue Engineering Research ›› 2015, Vol. 19 ›› Issue (6): 934-939.doi: 10.3969/j.issn.2095-4344.2015.06.020

Previous Articles     Next Articles

Co-transplantation of HLA-matched limbal stem cells and amniotic membrane for treatment of pterygium

Yang Jie, Zhang Jin-sha, Ying Feng   

  1. Second Affiliated Hospital of Xinjiang Medical University, Urumqi 830063, Xinjiang Uygur Autonomous Region, China
  • Received:2015-01-07 Online:2015-02-05 Published:2015-02-05
  • Contact: Zhang Jin-sha, Master, Master’s supervisor, Associate professor, Chief physician, Second Affiliated Hospital of Xinjiang Medical University, Urumqi 830063, Xinjiang Uygur Autonomous Region, China
  • About author:Yang Jie, Master, Second Affiliated Hospital of Xinjiang Medical University, Urumqi 830063, Xinjiang Uygur Autonomous Region, China

Abstract:

BACKGROUND: Co-transplantation of HLA-matched limbal stem cells and amniotic membrane is a new concept for the treatment of pterygium, which is characterized as few complications, fast recovery, and low relapse rate. This treatment has been widely used because of reduced rejections.
OBJECTIVE: To investigate the therapeutic effect of HLA-matched limbal stem cells and amniotic membrane co-transplantation in the treatment of pterygium.
METHODS: Forty-seven patients with pterygium (47 eyes) who underwent the co-transplantation of HLA-matched limbal stem cells and amniotic membrane from March 1, 2013 to April 30, 2014 were enrolled as test group. Another 40 patients with pterygium (47 eyes) who received traditional surgical method acted as control group. Therapeutic effectiveness and relapse were compared between the two groups.
RESULTS AND CONCLUSION: The 47 cases in the test group were successfully treated with no complications and rejections, and only one case suffered from incision infection but discharged from hospital after symptomatic treatment. After treatment, pterygium relapsed in 2 of 47 eyes in the test group and 15 of 47 eyes in the control group, and the relapse rates were 4.3% and 31.9%, respectively. Results from this study show that the co-transplantation of HLA-matched limbal stem cells and amniotic membrane for treatment of pterygium has fewer complications and lower relapse rate, which is an effective method for the treatment of pterygium.


中国组织工程研究杂志出版内容重点:干细胞;骨髓干细胞;造血干细胞;脂肪干细胞;肿瘤干细胞;胚胎干细胞;脐带脐血干细胞;干细胞诱导;干细胞分化;组织工程


全文链接:

Key words: Pterygium, Amnion, Limbus Corneae, Stem Cells

CLC Number: